- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02093312
Meals on Wheels, the Effect of a Home Food-delivery Service for Cancer Patients (RUMLE)
Meals on Wheels, a Randomized Controlled Study on the Effect of a Home Food-delivery Service for Cancer Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Despite the fact that nutritional deterioration has been associated with patients' functional impairment, the effect of individualized nutritional support or counselling to outpatients, focussing on ordinary food, have not yet been thoroughly explored (Ravasco P. et al. 2007). A few studies have investigated the effect of nutritional counselling on quality of life (QoL) in cancer patients after discharge (Ovesen et al. 1993, Persson et al. 2002, Isenring et al. 2004, Ravasco et al. 2005a, Ravasco et al. 2005b). However, there is to our knowledge not conducted any studies examining the effect of home delivered meals on QoL and other endpoints in outpatients suffering from cancer.
The overall objective of the study is to measure the effect of energy- and protein enriched home delivered meals vs. habitual diet in malnourished outpatients diagnosed with lung cancer. The intervention diet will consist of optional protein- and energy-dense main and in-between-meals. There will be 22 different main meals and 13 in-between meals to choose between. The meals are prepared by The Nordic Kitchen of Copenhagen University Hospital Herlev. The offered main meals will consist of a selection of warm dishes taken from the ordinary menu. The in-between meals are a collection of the Delights of Herlev (dishes previously shown to increase dietary intake among in-patients). The food will be delivered to the participants' home 3 times per week, and participants can order one warm dish and ad libitum in-between meals for each day.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Herlev, Denmark, 2730
- Herlev University Hsopital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Have a nutritional risk score ≥ 3 according to NRS-2002 (Kondrup J. et al. 2003)
- Be diagnosed with lung cancer
- Have a life expectancy > 12 weeks
- Not plan to loose weight or go on a diet
- Not plan to go on vacation for > 2 weeks during the study period
- Live at their own home
- Live ≤ 25 km from the hospital
- Be able to read, write and understand Danish
Exclusion Criteria:
- Receives food from a food-delivery service
- Have food allergies or intolerance
- Exclusively receives enteral or parenteral nutrition
- Suffers from cognitive impairment e.g. dementia
- Is terminal
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
The control group is not offered any home food-delivery service, but continues with their habitual diet
|
|
|
Experimental: Intervention group
The intervention group is offered home food-delivery service
|
A home food-delivery service is offered the intervention group of cancer patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life
Time Frame: 6 weeks (change from baseline)
|
To assess the Global QoL, a questionnaire from the European Organization for the Research and Treatment of Cancer (EORTC) QLQ-30, version 3, will be used.
This is a validated, cancer-specific questionnaire with a total of 30 questions, looking back at the past week.
The scoring of QoL is based on 2 specific questions with response options ranging from 1-7 which indicate very bad to very good.
A Danish version of the questionnaire will be used.
|
6 weeks (change from baseline)
|
|
Quality of Life
Time Frame: 12 weeks (change from baseline)
|
To assess the Global QoL, a questionnaire from the European Organization for the Research and Treatment of Cancer (EORTC) QLQ-30, version 3, will be used.
This is a validated, cancer-specific questionnaire with a total of 30 questions, looking back at the past week.
The scoring of QoL is based on 2 specific questions with response options ranging from 1-7 which indicate very bad to very good.
A Danish version of the questionnaire will be used.
|
12 weeks (change from baseline)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hand grip strength
Time Frame: 6, and 12 weeks (changes from baseline)
|
Hand grip strength (in kg) will be measured with a Hydraulic Hand Dynamometer.
Participants will be seated with forearms rested on the arms of the chair.
They are asked to perform three maximum force trials with their dominant hand and using the second handle position.
The test will be repeated within 30 seconds, and the maximum grip score from the three measured values will be used.
|
6, and 12 weeks (changes from baseline)
|
|
30-second chair-stand test
Time Frame: 6, and 12 weeks (changes from baseline)
|
The 30-second-chair-stand test consist of manually counting the number of sit-stand-sit cycles completed during the 30 seconds of the test.
A standard chair (with a seat height of 40cm) with or without a backrest but with armrests will be used.
Initially, subject will be seated on the chair with their back in an upright position.
They will be instructed to rise after the "1, 2, 3, go" command at their own preferred speed with their arms folded across their chest.
If the participant is only able to perform the test by using armrest, the test will be recorded as "modified".
|
6, and 12 weeks (changes from baseline)
|
|
Body Weight
Time Frame: 6, and 12 weeks (changes from baseline)
|
Body weight will be measured to the nearest 0.1 kg following standard procedures (i.e.
without shoes, minimal clothing).
|
6, and 12 weeks (changes from baseline)
|
|
Depression Scale
Time Frame: 6, and 12 weeks (changes from baseline)
|
The Center for Epidemiological Studies Depression scale (CES-D) is a short self-report scale designed to measure depressive symptoms (Hann D. et al. 1999).
The questionnaire contains 20 items, divided in four domains: Somatic Retarded Activity (7 items), Depressed Affect (5 items), Positive Affect (4 items), and Interpersonal Affect (2 items), and 2 single items that complete the total score.
The total score ranges from 0 to 60; a score of ≥16 indicates a depressed symptomatology.
The CES-D has been validated in several samples of cancer patients, and it is often administered to inpatients with cancer (Vodermaier A. et al. 2009).
A Danish version of the questionnaire will be used.
|
6, and 12 weeks (changes from baseline)
|
|
Total energy- and protein intake per day
Time Frame: 6, and 12 weeks (changes from baseline)
|
Dietary intake will be assessed by a dietary interview covering patient's dietary intake over the past week.
On basis of the dietary interview the total energy and protein intake per day is estimated.
A food database with energy- and protein content of various foods is used for the estimation.
|
6, and 12 weeks (changes from baseline)
|
|
Re-admissions with total length of stay (LOS)
Time Frame: 12 weeks, and 6 months
|
Data on re-admissions to the hospital and LOS will be collected from all participants medical charts (hospital medical system OPUS/GS).
|
12 weeks, and 6 months
|
|
Mortality
Time Frame: 12 weeks, and 6 months
|
Data on mortality will be collected from all participants' medical charts (hospital medical system OPUS/GS).
|
12 weeks, and 6 months
|
|
WHO Performance status
Time Frame: 6, and 12 weeks
|
6, and 12 weeks
|
|
|
Functional-score
Time Frame: 6 and 12 weeks
|
Using EORTC-QLQ-30 version 3 - looking back at the past week.
Out of the 30 questions the functional score is based on 15 specific questions with 4 response options indicating either: not at all, a little, some or a lot.
Involves questions related to physical-, role-, emotional-, cognitive- and social functioning.
|
6 and 12 weeks
|
|
Symptom-score
Time Frame: 6 and 12 weeks (changes from baseline)
|
Using EORTC-QLQ-30 version 3 - looking back at the past week.
Out of the 30 questions the symptom score is based on 13 specific questions with 4 response options indicating either: not at all, a little, some or a lot.
|
6 and 12 weeks (changes from baseline)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compliance
Time Frame: 1, 6, and 12 weeks
|
All patients in the intervention group are requested to daily fulfil a compliance sheet during the whole 12-week period, where the intake of intervention dishes will be recorded.
Project staff will review the completed sheets together with the study participant at mid-way (week 6) and at the final 12-week visit in order to minimize possible uncertainties.
Moreover, eventual side-effects and reasons for non-compliance will be recorded.
|
1, 6, and 12 weeks
|
|
Evaluation
Time Frame: 12 weeks
|
All the intervention participants will receive an evaluation form in order to assess the acceptability of the offered meals, the food-delivery service, and a possible price they would give for this particular food-delivery service.
|
12 weeks
|
|
Effect of social status on total energy- and protein intake
Time Frame: Baseline
|
Definition of social status: if the participant is living alone or not
|
Baseline
|
|
Correlation between compliance (intervention group) and Quality of life
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between total energy- and protein intake (all participants) and Quality of life
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between compliance (intervention group) and Body weight
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between compliance (intervention group) and Hand grib strength
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between compliance (intervention group) and 30-second chair-stand test
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between compliance (intervention group) and Depression score
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between compliance (intervention group) and Total energy- and protein intake
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between compliance (intervention group) and WHO performance status
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between total energy- and protein intake (all participants) and Hand grip strength
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between total energy- and protein intake (all participants) and Body weight
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between total energy- and protein intake (all participants) and 30 second chair-stand test
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between total energy- and protein intake (all participants) and Depression scale
Time Frame: 12 weeks
|
12 weeks
|
|
|
Correlation between total energy- and protein intake (all participants) and WHO performance status
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Arne V Astrup, Professor, University of Copenhagen
- Study Director: Eva Leedo, Cand Scient, University of Copenhagen
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EFFECT.A03.2014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Cancer
-
M.D. Anderson Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; MedWaves, IncRecruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCaregiver | Stage III Lung Cancer AJCC v7 | Stage I Lung Cancer AJCC v7 | Stage II Lung Cancer AJCC v7 | Stage IB Lung Cancer AJCC v7 | Stage IA Lung Cancer AJCC v7 | Stage IIA Lung Cancer AJCC v7 | Stage IIB Lung Cancer AJCC v7 | Stage IIIA Lung Cancer AJCC v7 | Stage IIIB Lung Cancer AJCC v7United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedStage IV Lung Cancer | Stage III Lung Cancer | Stage I Lung Cancer | Stage II Lung CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
Emory UniversityNational Cancer Institute (NCI)TerminatedLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
University of California, San FranciscoMerck Sharp & Dohme LLCWithdrawnLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
Clinical Trials on Home food-delivery service
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Cedars-Sinai Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The... and other collaboratorsRecruiting
-
Boston Medical CenterCompleted
-
Amref Health AfricaCompletedSchistosomiasis Infection | Soil Transmitted Helminth (STH) InfectionsKenya
-
Johns Hopkins UniversityUniversity of South Florida; NYU Langone Health; University of Minnesota; National... and other collaboratorsCompleted
-
Brown UniversityNational Institute on Aging (NIA); Meals on Wheels AmericaCompletedDementiaUnited States
-
London School of Hygiene and Tropical MedicineBill and Melinda Gates Foundation; Population Council; International Planned...CompletedPregnancy | HIVKenya, Swaziland
-
Thomas RostonUniversity of Calgary; Genome British Columbia; Genome AlbertaEnrolling by invitationNonischemic Cardiomyopathy | Dilated Cardiomyopathy (DCM)Canada
-
Cornell UniversityNew York UniversityCompleted
-
M.D. Anderson Cancer CenterNot yet recruiting